HEPATOTOXICITY OF FLUOROURACIL WITH N-PHOSPHONACETYL-L-ASPARTATE

被引：0
作者：
STENRAM, U
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1992年 / 117卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：90 / 91
页数：2
相关论文
共 50 条
[11]   Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa [J].
Harte, RJA ;
Matthews, JC ;
O'Reilly, SM ;
Tilsley, DWO ;
Osman, S ;
Brown, G ;
Luthra, SJ ;
Brady, F ;
Jones, T ;
Price, PM .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1580-1588
[12]   CLINICAL-TRIAL OF SEQUENTIAL N-PHOSPHONACETYL-L-ASPARTATE, THYMIDINE, AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CARCINOMA [J].
OCONNELL, MJ ;
MOERTEL, CG ;
RUBIN, J ;
HAHN, RG ;
KVOLS, LK ;
SCHUTT, AJ .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (10) :1133-1138
[13]   AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE [J].
ERLICHMAN, C .
RECENT RESULTS IN CANCER RESEARCH, 1980, 74 :65-71
[14]   PHASE I-II TRIAL OF N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5FU) [J].
ERLICHMAN, C ;
DONEHOWER, RC ;
KLECKER, R ;
CHABNER, BA .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR) :366-366
[15]   CENTRAL NERVOUS-SYSTEM (CNS) TOXICITY OF PALA (N-PHOSPHONACETYL-L-ASPARTATE) [J].
WILEY, RG ;
GRALLA, RJ ;
CARROLL, DS ;
KEMENY, N ;
YOUNG, CW ;
SYKES, MP .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR) :350-350
[16]   A PHASE-I TRIAL OF COMBINED THERAPY WITH N-PHOSPHONACETYL-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU) [J].
MESHAD, MW ;
ERVIN, TJ ;
JOHNSON, RK .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR) :341-341
[17]   CYTIDINE POTENTIATES N-PHOSPHONACETYL-L-ASPARTATE ACTIVITY IN HUMAN OVARIAN-CARCINOMA CELLS [J].
CHAN, TCK ;
HOWELL, SB .
FEDERATION PROCEEDINGS, 1985, 44 (04) :1143-1143
[18]   Design, synthesis, and evaluation of N-phosphonacetyl-L-aspartate derivatives as putative human ATCase inhibitors [J].
Doud, Mary ;
Wolf, Caitlin ;
Ponsart, Kirsten .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
[19]   Phase I trial of fluorouracil modulation by n-phosphonacetyl-l-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer [J].
Alexandre Hageboutros ;
Gary R. Hudes ;
Fran Greene ;
Frank P. LaCreta ;
James Brennan ;
Peter J. O'Dwyer .
Investigational New Drugs, 1997, 15 :139-145
[20]   Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside (MMPR), and leucovorin in patients with advanced cancer [J].
Hageboutros, A ;
Hudes, GR ;
Greene, F ;
LaCreta, FP ;
Brennan, J ;
ODwyer, PJ .
INVESTIGATIONAL NEW DRUGS, 1997, 15 (02) :139-145
12345